BOSTON (MarketWatch) -- Pfizer Inc. said early Friday that it has reached agreements to settle the vast majority of cases filed over its pain relievers Bextra and Celebrex, a move that will result in ...
FILE - Pfizer CEO Albert Bourla speaks during a ceremony in Thessaloniki, Greece, on Tuesday, Oct. 12, 2021. On Friday, Nov. 12, The Associated Press reported on stories circulating online incorrectly ...